Lanean...
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
BACKGROUND: We utilized miRNAs expression and clinical data to develop a prognostic signature for patients with lung adenocarcinoma, with respect to their overall survival, to identify high-risk subjects based on their miRNA genomic profile. METHODS: MiRNA expressions based on miRNA sequencing and c...
Gorde:
| Argitaratua izan da: | BMC Cancer |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325795/ https://ncbi.nlm.nih.gov/pubmed/30621620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5206-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|